GenomeScan
At GenomeScan, the company strives to provide excellent, powerful and fast NGS (New Generation Sequencing) services and bioinformatic solutions. These efforts will enable scientists and physicians to understand genetic diseases, identify biomarkers, conduct clinical studies, or create new molecular diagnostic tests. NGS has opened up exciting opportunities for genetic disease analysis and the development of personalized treatment strategies. The company has always welcomed quality challenges and has gained ISO / IEC 17025 and ISO 15189 certification for its services.
The company’s motto: Quality assurance brings outstanding customer confidence and trust.
GenomeScan, has the ability to provide desirable data for WES samples with reading depths of X100 and X200 in the field of NGS services, which has the highest amount of coverage. All WES tests are performed by Illumina platform and Agilent SureSelect Human All Exon V7 kits with a short response time of 5 to 6 weeks from the time of submission, for all medical genetics and research centers. It should be noted that all company files such as VCF, FASTQ and BAM files are provided to the costumer. The company can provide the answers with the best clinical reports to the requesting centers.
Genomescan has the ability to provide a genetic panel that examines more than 2,700 genes in targeted form:
- Highly targeted panel of over 2,700 regions implicated in inherited disease pathogenesis
- Specifically including the causative genes for rare diseases
- Deep and even coverage of all target genes compared to exome sequencing
- Choose between receiving the FastQ files (Package: ‘Data’), the VCF files (‘+ Analysis’) or a comprehensive report of the findings (‘+Diagnosis’)
- Data-interpretation by an experienced team of Clinical Laboratory Specialists
- Full report including interpretation in 5 to 6 week